The Latin America, Middle East and Africa Ultrasound Transducer Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 177.3 thousand units, showcasing a growth of 8.8% (2023-2030).
Point-of-care ultrasound examinations with handheld transducers are increasingly common in obstetrics and gynaecology practices. Healthcare providers can perform quick ultrasounds during prenatal visits to monitor fetal development, detect potential complications, and reassure expectant parents. Additionally, gynaecologists can use ultrasound transducers for on-the-spot evaluations of pelvic conditions, aiding in the timely diagnosis and treatment of reproductive health issues. One of the hallmarks of the market is continuous technological innovation. Manufacturers constantly strive to improve image quality, diagnostic accuracy, and user experience. These advancements have propelled the market forward and opened up new possibilities in healthcare.
Furthermore, emerging technologies like 3D/4D imaging have gained prominence, offering enhanced visualization and depth perception. Elastography, which measures tissue stiffness, aids in the detection of cancerous lesions. Using specialized contrast agents, contrast-enhanced ultrasound provides more precise images for improved diagnosis and monitoring. These innovations are expanding the range of applications for ultrasound transducers beyond traditional imaging. Moreover, developing portable and handheld ultrasound devices has democratized access to ultrasound technology. These devices, equipped with transducers, are increasingly used in point-of-care settings, remote healthcare, and even home healthcare applications. They empower healthcare providers to perform rapid diagnostic assessments at the patient's bedside, reducing the need for centralized imaging facilities and expediting patient care.
A well-known organization in Dubai devoted to medical education, research, and innovation is the Mohammed bin Rashid University of Medicine and Health Sciences (MBRU). To promote medical research and create qualified healthcare personnel, the government funds MBRU. The UAE government aggressively promotes healthcare investment by the private sector. Different free zones provide incentives and chances for foreign investors to set up healthcare facilities and businesses nationwide. Public healthcare facilities in Abu Dhabi are overseen and operated by SEHA, a government-owned business. The government budget 2022 included a total of USD 15.8 billion (AED 58.931 billion) for public spending, of which 8.4% would be used for healthcare. Therefore, the LAMEA region poses lucrative growth prospects for the market in the future.
The Brazil market dominated the LAMEA Ultrasound Transducer Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $99.6 million by 2030. The Argentina market is showcasing a CAGR of 8.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.6% during (2023 - 2030).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
Point-of-care ultrasound examinations with handheld transducers are increasingly common in obstetrics and gynaecology practices. Healthcare providers can perform quick ultrasounds during prenatal visits to monitor fetal development, detect potential complications, and reassure expectant parents. Additionally, gynaecologists can use ultrasound transducers for on-the-spot evaluations of pelvic conditions, aiding in the timely diagnosis and treatment of reproductive health issues. One of the hallmarks of the market is continuous technological innovation. Manufacturers constantly strive to improve image quality, diagnostic accuracy, and user experience. These advancements have propelled the market forward and opened up new possibilities in healthcare.
Furthermore, emerging technologies like 3D/4D imaging have gained prominence, offering enhanced visualization and depth perception. Elastography, which measures tissue stiffness, aids in the detection of cancerous lesions. Using specialized contrast agents, contrast-enhanced ultrasound provides more precise images for improved diagnosis and monitoring. These innovations are expanding the range of applications for ultrasound transducers beyond traditional imaging. Moreover, developing portable and handheld ultrasound devices has democratized access to ultrasound technology. These devices, equipped with transducers, are increasingly used in point-of-care settings, remote healthcare, and even home healthcare applications. They empower healthcare providers to perform rapid diagnostic assessments at the patient's bedside, reducing the need for centralized imaging facilities and expediting patient care.
A well-known organization in Dubai devoted to medical education, research, and innovation is the Mohammed bin Rashid University of Medicine and Health Sciences (MBRU). To promote medical research and create qualified healthcare personnel, the government funds MBRU. The UAE government aggressively promotes healthcare investment by the private sector. Different free zones provide incentives and chances for foreign investors to set up healthcare facilities and businesses nationwide. Public healthcare facilities in Abu Dhabi are overseen and operated by SEHA, a government-owned business. The government budget 2022 included a total of USD 15.8 billion (AED 58.931 billion) for public spending, of which 8.4% would be used for healthcare. Therefore, the LAMEA region poses lucrative growth prospects for the market in the future.
The Brazil market dominated the LAMEA Ultrasound Transducer Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $99.6 million by 2030. The Argentina market is showcasing a CAGR of 8.5% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.6% during (2023 - 2030).
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include GE HealthCare Technologies, Inc., Siemens Healthineers AG (Siemens AG), FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation), Hitachi, Ltd. (Hitachi Healthcare), SonoScape Medical Corp., Koninklijke Philips N.V., Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Esaote SpA
Scope of the Study
Market Segments Covered in the Report:
By Product Type (Volume, Thousand Units, USD Million, 2019-2030)- Convex
- Linear
- Phased Array
- Endocavitary
- CW Doppler
- Others
- Hospital
- Clinic
- Diagnostic Center
- ASCs
- General Imaging
- Cardiovascular
- Musculoskeletal
- Vascular
- OB/GYN
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- GE HealthCare Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
- Canon, Inc. (Canon Medical Systems Corporation)
- Hitachi, Ltd. (Hitachi Healthcare)
- SonoScape Medical Corp.
- Koninklijke Philips N.V.
- Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Esaote SpA
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Ultrasound Transducer Market by Product Type
Chapter 6. LAMEA Ultrasound Transducer Market by End Use
Chapter 7. LAMEA Ultrasound Transducer Market by Application
Chapter 8. LAMEA Ultrasound Transducer Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- GE HealthCare Technologies, Inc.
- Siemens Healthineers AG (Siemens AG)
- FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)
- Canon, Inc. (Canon Medical Systems Corporation)
- Hitachi, Ltd. (Hitachi Healthcare)
- SonoScape Medical Corp.
- Koninklijke Philips N.V.
- Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.)
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Esaote SpA
Methodology
LOADING...
